The White House plans to move forward with an interim final rule that would lower US drug prices by aligning prices paid by Medicare for certain drugs with those paid in other countries, sources told The Hill. The plan could be announced as soon as today, Politico reports. Pharmaceutical industry leaders told The Hill they may respond to the proposal with legal action.
White House to proceed with plan targeting drug prices
Sign up for ACG SmartBrief
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.